Skip to main content

Table 1 Baseline characteristics

From: High prevalence of peripheral arterial disease (PAD) in incident hemodialysis patients: screening by ankle-brachial index (ABI) and skin perfusion pressure (SPP) measurement

 

All patients (N = 185)

Age (years)

70 (61–78)

Male, n (%)

130 (70.2)

Hypertension, n (%)

148 (80.0)

Diabetes mellitus, n (%)

100 (54.1)

Dyslipidemia, n (%)

80 (43.2)

Ischemic heart disease, n (%)

74 (40.0)

Stroke, n (%)

27 (14.9)

ABI

1.18 (1.05–1.27)

SPP (mmHg)

73 (52–85)

Previous history of PAD, n (%)

13 (7.0)

Medications

 Cilostazol, n (%)

11 (5.9)

 Sarpogrelate, n (%)

1 (0.5)

 Aspirin, n (%)

48 (25.9)

 Prostaglandin analogue, n (%)

17 (9.2)

 Ticlopidine, n (%)

18 (9.7)

 Clopidogrel, n (%)

1 (0.5)

 Warfarin, n (%)

6 (3.2)

 Dipyridamole, n (%)

10 (4.9)

 Dilazep, n (%)

9 (5.4)

ARB, n (%)

74 (40.0)

 Statin, n (%)

60 (32.4)

  1. Data are presented as median (interquartile range)
  2. ABI ankle brachial pressure index, SPP skin perfusion pressure, PAD peripheral arterial disease, ARB angiotensinII receptor blocker
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us